Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript

IKS Health reported strong Q4 FY26 results with revenue of INR 857 crores (18.5% YoY growth, 5.2% QoQ growth) and EBITDA of INR 300 crores (35% margin). For FY26, revenue came in at INR 3,193 crores (~20% YoY growth), EBITDA at INR 1,091 crores (34%+), and PAT at INR 721 crores (48% YoY growth). The company demonstrated strong operating non-linearity with headcount growing only 5.3% YoY while revenue grew ~20%. Free cash flow generation was exceptional at INR 612 crores (85% of PAT), enabling debt reduction from a peak of INR 850 crores to INR 251 crores. Key strategic updates include progress on AI-native agentic platform transformation, completion of AQuity integration benefits, pending TruBridge acquisition for rural healthcare market entry, and new acqui-hire ARAI for neuro-symbolic AI capabilities.